6-Methyl-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine
≥95%
- Product Code: 50030
CAS:
1260769-87-6
| Molecular Weight: | 149.19 g./mol | Molecular Formula: | C₈H₁₁N₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD13193481 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, away from light, stored in an inert gas |
Product Description:
This chemical is primarily utilized in pharmaceutical research and development, particularly in the synthesis of bioactive compounds. It serves as a key intermediate in the creation of potential drug candidates targeting neurological disorders, such as Parkinson's disease and Alzheimer's disease, due to its structural similarity to neurotransmitters. Additionally, it is explored for its potential in designing molecules with antipsychotic and antidepressant properties. Its versatile structure also makes it valuable in medicinal chemistry for optimizing drug efficacy and selectivity. Researchers often employ it in the development of novel therapeutic agents, leveraging its tetrahydropyrido-pyrazine core to enhance binding affinity and metabolic stability.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿2,574.00 |
+
-
|
| 0.250 | 10-20 days | ฿4,293.00 |
+
-
|
| 1.000 | 10-20 days | ฿12,897.00 |
+
-
|
6-Methyl-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine
This chemical is primarily utilized in pharmaceutical research and development, particularly in the synthesis of bioactive compounds. It serves as a key intermediate in the creation of potential drug candidates targeting neurological disorders, such as Parkinson's disease and Alzheimer's disease, due to its structural similarity to neurotransmitters. Additionally, it is explored for its potential in designing molecules with antipsychotic and antidepressant properties. Its versatile structure also makes it valuable in medicinal chemistry for optimizing drug efficacy and selectivity. Researchers often employ it in the development of novel therapeutic agents, leveraging its tetrahydropyrido-pyrazine core to enhance binding affinity and metabolic stability.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :